AGI.do

Products

What will AGI do for Automated coombs test systems?

In this classification, an automated Coombs test system is a device used to detect and identify antibodies in patient sera or antibodies bound to red cells. The Coombs test is used for the diagnosis of hemolytic disease of the newborn, and autoimmune hemolytic anemia. The test is also used in cross matching and in investigating transfusion reactions and drug-induced red cell sensitization. US FDA regulates Automated coombs test systems under 21 CFR 864.9300 and under FDA product code KSM.

How AGI delivers it

Four ways AGI delivers for Automated coombs test systems

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Automated coombs test systems, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Automated coombs test systems, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Automated coombs test systems connects

measured by

  • Agglutination Grading Accuracymodel
  • Carryover Ratemodel
  • Test Throughputmodel
  • Throughput Per Hourmodel
  • Time To First Resultmodel

Go deeper

Explore Automated coombs test systems

Read the deeper take on agi.asView as markdown